Novartis has a long heritage and legacy in Malaysia. Established in 1971, we are a leading multinational company employing close to 600 associates who work in the Novartis International division and Novartis Corporate Center, Kuala Lumpur.
Through our over 50-year presence in Malaysia, Novartis Malaysia continues to deliver on its corporate purpose of reimagining medicine to improve and extend the lives of over 32 million Malaysians.
- Contribution to Malaysia’s GDP. In 2023, Novartis contributed a total of almost RM1.05 billion towards Malaysia’s GDP through direct and indirect business activities
- Employment. 85% of our associates are Malaysians with Novartis recognized as Top Employer in 2024 for fifth year running
- Clinical Trials (CT). In 2022, Novartis Malaysia initiated 24 new clinical trials and invested approximately RM53.56 million in 79 ongoing studies, which amounts to over 25% of the total study value in Malaysia
In 2022, Novartis Malaysia was recognized as Sponsor of the Year by Clinical Research Malaysia. We also have a proven track record of expanding access to our innovative medicines in private or public via collaborations with the Ministry of Health Malaysia. Through these collaborations, Novartis has succeeded in touching the lives of more than 1.2 million Malaysian patients.
Novartis Malaysia’s office is located in the new cutting-edge building called Plaza Imazium in Damansara Utama, Petaling Jaya. Novartis Malaysia occupies 2 floors and was one of 20 offices in Malaysia to be LEED Gold certified and the first office to be WELL Silver certified.